Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma

Published version of a preprint

Abstract

Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor that tends to be resistant to the ionizing radiotherapy used to treat it. Because TGF-β is a modifier of radiation responses, we conducted a preclinical study of the antitumor effects of the TGF-β receptor (TGFβR) I kinase inhibitor LY2109761 in combination with radiotherapy. LY2109761 reduced clonogenicity and increased radiosensitivity in GBM cell lines and cancer stem–like cells, augmenting the tumor growth delay produced by fractionated radiotherapy in a supra-additive manner in vivo. In an orthotopic intracranial model, LY2109761 significantly reduced tumor growth, prolonged survival, and extended the prolongation of survival induced by radiation treatment. Histologic analyses showed that LY2109761 inhibited tumor invasion promoted by radiation, reduced tumor microvessel density, and attenuated mesenchymal transition. Microarray-based gene expression analysis revealed signaling effects of the combinatorial treatments that supported an interpretation of their basis. Together, these results show that a selective inhibitor of the TGFβR-I kinase can potentiate radiation responses in glioblastoma by coordinately increasing apoptosis and cancer stem–like cells targeting while blocking DNA damage repair, invasion, mesenchymal transition, and angiogenesis. Our findings offer a sound rationale for positioning TGFβR kinase inhibitors as radiosensitizers to improve the treatment of glioblastoma. Cancer Res; 71(23); 7155–67. ©2011 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-1212

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

See all 259

Metadata

Authors
Zhang, M., Kleber, S., Röhrich, M., Timke, C., Han, N., Tuettenberg, J., Martin-Villalba, A., Debus, J., Peschke, P., Wirkner, U., Lahn, M., & Huber, P. E.
Affiliations
  • German Cancer Research Center (DE)
  • Eli Lilly (United States) (US)
  • Authors' Affiliations: 1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China; Departments of 2Radiation Oncology and 3Neurobiology of Brain Tumors, German Cancer Research Center (DKFZ); 4Department of Radiation Oncology, University Hospital Center, Heidelberg; 5SHG-Klinik Idar-Oberstein Klinik für Neurochirurgie, 2 Dr.-Ottmar-Kohler-Straße, Idar-Oberstein, Germany; and 6Oncology Early Clinical Investigation, Lilly Research Laboratories, Indianapolis, Indiana
Corresponding author
Huber, Peter E.
Venue
Cancer Research
Published
2011-11-29
Volume
71
Issue
23
Pages
7155-7167
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2045318349
Cited by
249
References
49
Citations by year
2026: 7 · 2025: 11 · 2024: 6 · 2023: 8 · 2022: 9 · 2021: 35 · 2020: 16 · 2019: 12 · 2018: 20 · 2017: 20 · 2016: 20 · 2015: 21 · 2014: 26 · 2013: 19 · 2012: 19
FWCI
10.32
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
glioblastoma, TGF-beta signaling, LY2109761, radiosensitization, radiotherapy resistance, combination therapy, cancer stem-like cells, mesenchymal transition, tumor invasion, angiogenesis, DNA repair, apoptosis, tumor microvessel density
MeSH terms
Receptor, Transforming Growth Factor-beta Type I, Animals, Brain Neoplasms, DNA Damage, DNA Repair, Glioblastoma, Humans, Mice, Inbred BALB C, Neoplasm Invasiveness, Neovascularization, Pathologic, Pyrazoles, Pyrroles, Radiation Tolerance, Radiation-Sensitizing Agents, Neoplastic Stem Cells, Signal Transduction, Transforming Growth Factor beta, Mice, SCID, Apoptosis, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Xenograft Model Antitumor Assays, Cell Line, Tumor, Microarray Analysis, Protein Kinase Inhibitors, Cell Proliferation, Mice, Smad2 Protein, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-1212
The paper
Zhang, M., Kleber, S., Röhrich, M., Timke, C., Han, N., Tuettenberg, J., Martin-Villalba, A., Debus, J., Peschke, P., Wirkner, U., Lahn, M., & Huber, P. E. (2011). Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-1212

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.